Catalyst Wire Dossier Catalyst Wire Dossier

BosSTENT

· Sonorous NV, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BosSTENT, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus [NA]

See pricing